http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7430b5f2de40bbc84c376cdb64ee0edf
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Reinherz |
| name | Ellis L Reinherz Ellis L. Reinherz |
| given-name | Ellis L Ellis L. |
| organization-name | Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute and; Department of Medicine, Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Medicine, Harvard Medical School, Boston, MA 02115; Cancer Vaccine Center Dana‐Farber Cancer Institute and Harvard Medical School Boston MA USA; Laboratory of Immunobiology, Department of Medical Oncology Dana‐Farber Cancer Institute and Department of Medicine Harvard Medical School Boston MA USA Division of Tumor Immunology, Sidney Farber Cancer Institute-Harvard Medical School From the , Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115; and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 Division of Tumor Immunology, Sidney Farber Cancer Institute—Harvard Medical School From the , Boston, Massachusetts 02115 and the , Raritan, New Jersey 08869; Division of Immunosciences, Ortho Pharmaceutical Corporation From the , Boston, Massachusetts 02115 and the , Raritan, New Jersey 08869 Dana-Farber Cancer Institute 3 Laboratory of Immunobiology and Department of Medical Oncology, , Boston, Massachusetts 02115, USA; Harvard Medical School 4 Departments of Medicine, , Boston, Massachusetts 02115, USA Cancer Vaccine Center and Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts 02115 and , Raritan, New Jersey 08869; Division of Immunosciences, Ortho Pharmaceutical Corporation , Boston, Massachusetts 02115 and , Raritan, New Jersey 08869 Laboratory of Immunobiology and Department of Medical Oncology, Dana Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115. Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, USA. Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA ; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115, USA ; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. aLaboratory of Immunobiology and Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02115 Multiple Sclerosis Unit of the Center for Neurologic Diseases, Division of Neurology, the Brigham and Women's Hospital; the Division of Tumor Immunology, Dana Farber Cancer Institute; and the Harvard Medical School, Boston, MA. §Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115 Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana–Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Department of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Medicine, Harvard Medical School, Boston, MA 02115; and Harvard Medical School, Division of Tumor Immunology, Sidney Farber Cancer Institute From the , Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. ‡Laboratory of Immunobiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 *Laboratory of Immunobiology, Department of Medical Oncology, Dana Farber Cancer Institute, and; †Department of Medicine, Harvard Medical School, Boston, MA 02115; Dana-Farber Cancer Institute, Boston, Massachusetts 02115 Department of Biological Chemistry and Molecular Pharmacology and Laboratory of Immunobiology, Departments of Medical Oncology and Medicine, and Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 From the Laboratory of Immunobiology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 Department of Medical Oncology, Laboratory of Immunobiology,; Cancer Vaccine Center, Dana-Farber Cancer Institute, and; Department of Medicine, Harvard Medical School, Boston, MA 02115; Department of Neuroscience (Drs. Hauser and Weiner and Ms. Hoban), Children's Hospital Medical Center and the Division of Neurology, Department of Medicine, Brigham and Women's Hospital, and the Division of Tumor Immunology (Drs. Reinherz and Schlossman), Sidney Farber Cancer Institute, Boston, MA. Cancer Vaccine Center and; Laboratory of Immunobiology and Department of Medical Oncology, Dana–Farber Cancer Institute, Boston, MA 02115;; Departments of bMedicine, Department of Neurosciences Children's Hospital Medical Center and the Division of Neurology Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115. Laboratory of Immunobiology, Dana-Farber Cancer Institute, and the Departments of Pathology and Medicine, Harvard Medical School, Boston, MA 02115. *Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, and; †Department of Medicine and Department of Medical Oncology Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA; Cancer Vaccine Center Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA Laboratory of Immunobiology, Dana-Farber Cancer Institute; Boston MA 02115 USA; Department of Medicine; Boston MA 02115 USA *Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; and; † Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; and Department of Medicine, Harvard Medical School, Boston, MA 02115 *Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;; †Department of Medicine, Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, United States *Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; and; †Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute,; Department of Medicine, Laboratory of Immunobiology and Division of Adult Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Medicine, Harvard Medical School, Boston, MA 02115; Laboratory of Immunobiology, Dana-Farber Cancer Institute, and Departments of Pathology and Medicine, Harvard Medical School, Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology and Department of Medical Oncology Dana‐Farber Cancer Institute and Departments Harvard Medical School Boston MA USA; Medicine Harvard Medical School Boston MA USA Division of Tumor Immunology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA Laboratory of Immunobiology, Dana-Farber Cancer Institute, and the Department of Medicine and the Department of Pathology, Harvard Medical School, Boston, MA 02115. *Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute and Departments of; †Medicine and Division of Tumor Immunology, Dana- Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;; Department of Medicine, Harvard Medical School, Boston, MA 02115; Division of Tumor Immunology, Dana-Farber Cancer Institute, and Departments of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 Authors' Affiliations: 1Cancer Vaccine Center and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Dermatology, Brigham and Women's Hospital and Harvard Skin Disease Research Center, Harvard Medical School; 4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Cancer Vaccine Center and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Dermatology, Brigham and Women's Hospital and Harvard Skin Disease Research Center, Harvard Medical School; 4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Cancer Vaccine Center and 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Dermatology, Brigham and Women's Hospital and Harvard Skin Disease Research Center, Harvard Medical School; 4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 1Laboratory of Immunobiology, Dana-Farber Cancer Institute; 2Department of Medicine, Harvard Medical School, Boston, MA 02115 1Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. Laboratory of Immunobiology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02115 Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115 and Harvard Medical School, Boston, MA 02115 Division of Tumor Immunology, Sidney Farber Cancer Institute, Boston, Massachusetts 02115 Laboratory of Immunobiology and Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, and Departments of Pediatrics, Biological Chemistry and Molecular Pharmacology, and Medicine, Harvard Medical School, Boston, MA 02115; and Biosciences Division, Argonne National Laboratory, Argonne, IL 60439 Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 |
Incoming Links
Total number of triples: 348.